These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 26983452)

  • 21. Can the painDETECT Questionnaire score and MRI help predict treatment outcome in rheumatoid arthritis: protocol for the Frederiksberg hospital's Rheumatoid Arthritis, pain assessment and Medical Evaluation (FRAME-cohort) study.
    Rifbjerg-Madsen S; Christensen AW; Boesen M; Christensen R; Danneskiold-Samsøe B; Bliddal H; Bartels EM; Locht H; Amris K
    BMJ Open; 2014 Nov; 4(11):e006058. PubMed ID: 25394817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health-related quality of life in patients with long-standing rheumatoid arthritis in the era of biologics: data from the German biologics register RABBIT.
    Gerhold K; Richter A; Schneider M; Bergerhausen HJ; Demary W; Liebhaber A; Listing J; Zink A; Strangfeld A
    Rheumatology (Oxford); 2015 Oct; 54(10):1858-66. PubMed ID: 26001633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can baseline ultrasound results help to predict failure to achieve DAS28 remission after 1 year of tight control treatment in early RA patients?
    Ten Cate DF; Jacobs JWG; Swen WAA; Hazes JMW; de Jager MH; Basoski NM; Haagsma CJ; Luime JJ; Gerards AH
    Arthritis Res Ther; 2018 Jan; 20(1):15. PubMed ID: 29382379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Characteristics and Cytokine Profiles of Organizing Pneumonia in Patients with Rheumatoid Arthritis Treated with or without Biologics.
    Kawasumi H; Gono T; Tanaka E; Kaneko H; Kawaguchi Y; Yamanaka H
    J Rheumatol; 2016 Apr; 43(4):738-44. PubMed ID: 26834212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative effectiveness of nonbiologic versus biologic disease-modifying antirheumatic drugs for rheumatoid arthritis.
    Dewitt EM; Li Y; Curtis JR; Glick HA; Greenberg JD; Anstrom KJ; Kremer JM; Reed G; Schulman KA; Reed SD
    J Rheumatol; 2013 Feb; 40(2):127-36. PubMed ID: 23322461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of biologic DMARDs in monotherapy versus in combination with synthetic DMARDs in rheumatoid arthritis: data from the Swiss Clinical Quality Management Registry.
    Gabay C; Riek M; Scherer A; Finckh A;
    Rheumatology (Oxford); 2015 Sep; 54(9):1664-72. PubMed ID: 25922549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contribution of the subjective components of the disease activity score to the response to biologic treatment in rheumatoid arthritis.
    Jurgens MS; Overman CL; Jacobs JW; Geenen R; Cuppen BV; Marijnissen AC; Bijlsma JW; Welsing PM; Lafeber FP; van Laar JM;
    Arthritis Care Res (Hoboken); 2015 Jul; 67(7):923-8. PubMed ID: 25504811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors associated with the initiation of biologic disease-modifying antirheumatic drugs in Texas Medicaid patients with rheumatoid arthritis.
    Kim G; Barner JC; Rascati K; Richards K
    J Manag Care Spec Pharm; 2015 May; 21(5):401-7. PubMed ID: 25943001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of discrimination and prognostic value of two US Doppler scoring systems in rheumatoid arthritis patients: a prospective cohort study.
    Ellegaard K; Terslev L; Christensen R; Szkudlarek M; Schmidt WA; Jensen PS; Bliddal H; Torp-Pedersen S
    Clin Exp Rheumatol; 2014; 32(4):495-500. PubMed ID: 24960526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive value of Doppler ultrasound-detected synovitis in relation to failed tapering of biologic therapy in patients with rheumatoid arthritis.
    Naredo E; Valor L; De la Torre I; Montoro M; Bello N; Martínez-Barrio J; Martínez-Estupiñán L; Nieto JC; Ovalles-Bonilla JG; Hernández-Flórez D; González CM; López-Longo FJ; Monteagudo I; Carreño L
    Rheumatology (Oxford); 2015 Aug; 54(8):1408-14. PubMed ID: 25731769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Very early improvements in the wrist and hand assessed by power Doppler sonography predicting later favorable responses in tocilizumab-treated patients with rheumatoid arthritis.
    Kume K; Amano K; Yamada S; Hatta K; Kuwaba N; Ohta H
    Arthritis Care Res (Hoboken); 2011 Oct; 63(10):1477-81. PubMed ID: 21702090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronological changes in baseline disease activity of patients with rheumatoid arthritis who received biologic DMARDs between 2003 and 2012.
    Sato E; Tanaka E; Ochiai M; Shimizu Y; Kobayashi A; Shidara K; Hoshi D; Sugimoto N; Inoue E; Seto Y; Nakajima A; Taniguchi A; Momohara S; Yamanaka H
    Mod Rheumatol; 2015 May; 25(3):350-7. PubMed ID: 25619283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overweight decreases the chance of achieving good response and low disease activity in early rheumatoid arthritis.
    Sandberg ME; Bengtsson C; Källberg H; Wesley A; Klareskog L; Alfredsson L; Saevarsdottir S
    Ann Rheum Dis; 2014 Nov; 73(11):2029-33. PubMed ID: 24818635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Which variables best predict change in rheumatoid arthritis therapy in daily clinical practice?
    Soubrier M; Zerkak D; Gossec L; Ayral X; Roux C; Dougados M
    J Rheumatol; 2006 Jul; 33(7):1243-6. PubMed ID: 16622906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficient management of rheumatoid arthritis significantly reduces long-term functional disability.
    Tanaka E; Mannalithara A; Inoue E; Hara M; Tomatsu T; Kamatani N; Singh G; Yamanaka H
    Ann Rheum Dis; 2008 Aug; 67(8):1153-8. PubMed ID: 17971459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gain in quality-adjusted life-years in patients with rheumatoid arthritis during 1 year of biological therapy: a prospective study in clinical practice.
    Linde L; Sørensen J; Østergaard M; Hetland ML
    J Rheumatol; 2013 Sep; 40(9):1479-86. PubMed ID: 23818719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ultrasound Assessment of Disease Activity Prevents Disease-Modifying Antirheumatic Drug (DMARD) Escalation and May Reduce DMARD-Related Direct Costs in Rheumatoid Arthritis With Fibromyalgia: An Exploratory Study.
    Silva Chakr RMD; Santos JCO; Alves LDS; de Andrade NPB; Ranzolin A; Brenol CV
    J Ultrasound Med; 2020 Jul; 39(7):1271-1278. PubMed ID: 31958164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of change in bodily pain in early rheumatoid arthritis: an inception cohort study.
    McWilliams DF; Zhang W; Mansell JS; Kiely PD; Young A; Walsh DA
    Arthritis Care Res (Hoboken); 2012 Oct; 64(10):1505-13. PubMed ID: 22556121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ultrasound-detected activity in rheumatoid arthritis on methotrexate therapy: Which joints and tendons should be assessed to predict unstable remission?
    Janta I; Valor L; De la Torre I; Martínez-Estupiñán L; Nieto JC; Ovalles-Bonilla JG; Martínez-Barrio J; Bello N; Hinojosa M; Montoro M; González CM; López-Longo J; Monteagudo I; Carreño L; Naredo E
    Rheumatol Int; 2016 Mar; 36(3):387-96. PubMed ID: 26712373
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physician global assessment at 3 months is strongly predictive of remission at 12 months in early rheumatoid arthritis: results from the CATCH cohort.
    Choy T; Bykerk VP; Boire G; Haraoui BP; Hitchon C; Thorne C; Keystone EC; Pope JE;
    Rheumatology (Oxford); 2014 Mar; 53(3):482-90. PubMed ID: 24241035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.